Results 101 to 110 of about 33,699 (271)

A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy [PDF]

, 2017
Background: The effectiveness of drugs aimed at counteracting cancer cachexia is generally tested in pre-clinical rodent models, where only the tumour-induced alterations are taken into account, excluding the co-presence of anti-tumour molecules that ...
Argilés Huguet, Josep Ma., Betancourt Suárez, Angélica Maritza, Busquets Rius, Sílvia, Filomena Marmonti, Enrica, Luque, Melania, López-Soriano, Francisco J., Oliva Cuyàs, Francesc, Penna, Fabio, Toledo Soler, Miriam   +8 more
core   +1 more source

Inhaler Competence and Patient Satisfaction with Easyhaler: Results of Two Real-Life Multicentre Studies in Asthma and COPD. [PDF]

, 2013
OBJECTIVE: The aim of this study was to investigate patients' inhaler competence and satisfaction with the Easyhaler(R) dry powder inhaler. DESIGN: Two open, uncontrolled, non-randomised studies.
Gabriella Gálffy, Gyula Németh, Györgyi Mezei, Lilla Tamási, Marta Orosz, Olof Selroos, Veronika Müller   +6 more
core   +2 more sources

The Real‐World Analysis of Adverse Events With Two Types of Single‐Inhaler Triple Therapy: A VigiAccess Database Study

Journal of Clinical Pharmacy and Therapeutics, Volume 2025, Issue 1, 2025.
Background The advent of single‐inhaler triple therapies (SITTs), including fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) and beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FOR/GLY), has expanded treatment options for chronic obstructive pulmonary disease (COPD).
Baiquan Zhang, Jiayu Bai, Lu Zhou, Hongda Liu   +3 more
wiley   +1 more source

The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies. [PDF]

, 2016
BACKGROUND: Reducing the severity of respiratory symptoms is a key goal in the treatment of chronic obstructive pulmonary disease (COPD). We evaluated the effect of aclidinium bromide 400 μg twice daily (BID) on respiratory symptoms, assessed using the ...
AD D’Urzo, D Singh, DA Mahler, DA Mahler, H Mullerova, JF Donohue, L Polley, M Miravitlles, MK Han, N Roche, NK Leidy, NK Leidy, NK Leidy, NK Leidy, PR Burgel, PW Jones, PW Jones, PW Jones, PW Jones, PW Jones   +19 more
core   +1 more source

Tools for clinical pharmacists to identify medications that can cause drug‐induced cognitive impairment: A systematic review

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 7, Issue 12, Page 1207-1227, December 2024.
Abstract Cognitive impairment affects around 19% of community‐dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive‐impairing medications through cognitive‐focused medication reviews or as part of comprehensive medication management.
Jacob Stanton, Michael R. Gionfriddo, Gail B. Rattinger, Yuan Fang, Mia E. Lussier   +4 more
wiley   +1 more source

Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids. [PDF]

, 2015
BACKGROUND: Asthma is the most common chronic medical condition among children and is one of the most common causes of hospitalisation and medical visits.
Aalbers, Adams, Adams, Ahmad, Anderson, Barnes, Berger, Bijl-Hofland, Brown, Brozek, Bumbacea, Bush, Cates, Cates, Cates, Cowie, Crane, Dorinsky, Dorinsky, Ducharme, Ducharme, Ernst, FitzGerald, FitzGerald, Fowler, Godard, Godard, Harrison, Hernández, Ind, Johnston, Koenig, Koenig, Lemanske, Lipworth, Liu, McMahon, Nathan, Nathan, Nelson, Nelson, Ni Chroinin, Obase, Oppenheimer, Paggiaro, Paggiaro, Papi, Pruteanu, Reddel, Rumbak, Salpeter, Self, Shamsul, Slankard, Spycher, Tattersfield, Wilding, Zangrilli, Zhang, Zhang   +59 more
core   +1 more source

Two cases of respiratory infection due to Pasteurella multocida: Acute and chronic form

Respirology Case Reports, Volume 12, Issue 5, May 2024.
We present two cases of respiratory infection caused by P. multocida, effectively managed with penicillin antibiotics, illustrating both chronic and acute courses. These cases indicate the importance of considering P. multocida in respiratory infections, given the patients' history of pet ownership and the nonspecific imaging findings and symptoms ...
Hironoshin Onizuka, Akihiro Hara, Kotaro Shiratori, Akito Yamamoto, Toshihiro Shirai   +4 more
wiley   +1 more source

Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma

Archives of Pharmacy Practice, 2014
Objective: This study was aimed to compare the efficacy between long-acting beta 2-agonists and leukotriene receptor antagonists as add-on therapy to inhaled corticosteroids in moderate persistent asthma.
Sasikala Kumaravel, Kingston Rajiah, Suchandra Sen   +2 more
doaj   +1 more source

Relationship Between Prior Inhaled Corticosteroid Use and Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate on Exacerbation Risk in Patients with Chronic Obstructive Pulmonary Disease: Analysis from the ETHOS Study [PDF]

, 2021
Diksha Singh, Klaus F. Rabe, F.J. Martinez, Martin Jenkins, Mehul S. Patel, Paul Dorinsky   +5 more
openalex   +1 more source

Pulmonary artery pseudoaneurysm after thoracic radiation therapy: A case report and review of the literature

Respirology Case Reports, Volume 12, Issue 4, April 2024.
A pulmonary pseudo‐aneurysm can present with moderate to massive haemoptysis. Potential causes include trauma, infection, cancer, or iatrogenic causes such as (chemo)radiotherapy. The gold standard for diagnosis is a CTA of the chest with contrast in pulmonary circulation, and endovascular embolization is an effective treatment in most cases.
Gerdinique (G. C.) Maessen, Thijs ( T. W.) Hoffman, Lidwien ( L.) Graat‐Verboom, Marc ( M.) van Leersum, Hans‐Jurgen ( J. J.) Mager   +4 more
wiley   +1 more source